The company primarily trades various grades of imported thermal coal for industrial use and manages a real estate division involved in land development and property leasing.
The company operates in highly commoditized sectors—coal trading and land development—where it lacks scale or cost advantages. Financial metrics contradict any moat claim, as evidenced by a massive 81% revenue collapse in FY24 and persistent negative net margins over the long term.
Capital has been trapped in non-performing assets and long-term disputes. The company has repeatedly extended the redemption period for its 2% cumulative preference shares (now to 2026) due to an inability to settle these obligations, while reinvestment has failed to generate positive revenue growth.
The company's death spiral accelerated as the inability to secure working capital turned a temporary revenue collapse into a permanent cessation of operations. By 2029, the repeated extensions of preference share redemptions finally hit a wall of legal mandates, forcing a liquidation of non-performing land assets at fire-sale prices to cover decades-old statutory disputes. The lack of a viable business model in commoditized coal trading meant that once the bank credit lines remained frozen, the company became a hollow shell, leaving equity holders with nothing but the remnants of a failed land-development dream.
RichFakir rates Hemang Resources Ltd's business quality as poor — 13/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Hemang Resources Ltd is trading about 65% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Hemang Resources Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Hemang Resources Ltd's fair value is about ₹25 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →